dabigatran has been researched along with Heart Diseases in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 19 (79.17) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Budnik, M; Ciba-Stemplewska, A; Filipiak, KJ; Gawałko, M; Gorczyca-Głowacka, I; Jurek, A; Kapłon-Cieślicka, A; Krzesiński, P; Opolski, G; Scisło, P; Uziębło-Życzkowska, B; Wożakowska-Kapłon, B | 1 |
| Fredenburgh, JC; Jaffer, IH; Stafford, A; Weitz, JI; Whitlock, RP | 1 |
| Abdelmaseeh, P; Asinger, R; Megaly, M; Sedhom, R | 1 |
| Egred, M; Farag, M; Gorog, DA; Gue, YX; Spinthakis, N | 1 |
| Bayer, N; Geidel, S; Hassan, K; Oberhoffer, M; Schlingloff, F; Schmoeckel, M; Wohlmuth, P | 1 |
| Cheung, JW; D'Amato, S; Gabriels, J; Ip, JE; Khan, M; Lerman, B; Liu, CF; Markowitz, SM; Patel, A; Shaban, N; Singh, P; Thomas, G; Wu, M | 1 |
| Fredgart, M; Gill, S | 1 |
| Chen, W; Gao, D; Gao, G; He, Y; Lakin, R; Liu, X; Sun, H; Wang, Y; Yan, M; Yang, H; Yang, P; Yu, M; Zhao, Q | 1 |
| Ageno, W; Agnelli, G; Chan, NC; De Caterina, R; Diener, HC; Hylek, E; Lip, GYH; Raskob, GE; Siegal, DM; Verheugt, FWA; Weitz, JI | 1 |
| Nagamoto, Y; Sadamatsu, K; Shiomi, T | 1 |
| Ajiro, Y; Iwade, K; Morita, S; Uchida, Y | 1 |
| Hayashida, K; Koga, Y; Matsuura, T; Mine, D; Nagamoto, Y; Okahara, A; Sadamatsu, K; Shiomi, T; Shirahama, T; Takegami, K; Yoshida, K | 1 |
| Braun, G; Messmann, H | 1 |
| Lee, CL; Tsao, HM; Wang, HH | 1 |
| Marciniak, ET; McCurdy, MT; Reed, RM; Weiler, B | 1 |
| Berghold, A; Kemperdick, B; Mergenthal, K; Petersen, JJ; Rauck, S; Roehl, I; Schulz-Rothe, S; Siebenhofer, A; Ulrich, LR | 1 |
| Gellér, L; Merkely, B; Szegedi, N; Széplaki, G; Tahin, T | 1 |
| Albuquerque, FP; Aras, R; de Almeida Nunes, B; de Bulhões, FV; de Souza Fernandes, AM; de Souza Roriz, P; Durães, AR | 1 |
| Durian, MF; Janssen, AM; Szabó, B; van de Kerkhof, D; van der Voort, PH | 1 |
| Albers, L; Bolt, J; Duffy, P; Hager, N; Semchuk, W; Wojcik, W | 1 |
| Vanerio, G; Vidal, A | 1 |
| Gil Núñez, A | 1 |
| Boodhwani, M; Hynes, M; Labinaz, M; Price, J; Ruel, M | 1 |
| Büller, HR; Di Nisio, M; Middeldorp, S | 1 |
6 review(s) available for dabigatran and Heart Diseases
| Article | Year |
|---|---|
Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review.
Topics: Dabigatran; Factor Xa Inhibitors; Heart Diseases; Heart Ventricles; Humans; Off-Label Use; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis; Treatment Outcome | 2020 |
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Antithrombins; Dabigatran; Embolism; Factor Xa Inhibitors; Heart Diseases; Heart Ventricles; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis; Warfarin | 2021 |
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Atrial Fibrillation; Benzamides; Biomarkers; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Drug Administration Schedule; Factor Xa; Heart Diseases; Humans; Piperazines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Risk; Rivaroxaban; Stroke; Thiazoles; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin | 2019 |
[Gastrointestinal bleeding in cardiological patients].
Topics: Algorithms; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Drug Monitoring; Gastrointestinal Hemorrhage; Heart Diseases; Humans; Metabolic Clearance Rate; Morpholines; Phenprocoumon; Platelet Aggregation Inhibitors; Platelet Transfusion; Rivaroxaban; Thiophenes; Vitamin K | 2013 |
Dabigatran and left atrial appendage thrombus.
Topics: Antithrombins; Atrial Appendage; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Diseases; Humans; Middle Aged; Thrombosis; Warfarin | 2012 |
[Prevention of cardioembolic stroke].
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fibrinolytic Agents; Heart Diseases; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Multicenter Studies as Topic; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Single-Blind Method; Thrombophilia; Vitamin K | 2012 |
1 trial(s) available for dabigatran and Heart Diseases
| Article | Year |
|---|---|
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study.
Topics: Adolescent; Adult; Antithrombins; Atrial Fibrillation; Bioprosthesis; Cardiac Valve Annuloplasty; Dabigatran; Female; Heart Diseases; Humans; Male; Middle Aged; Pilot Projects; Thrombosis; Treatment Outcome; Warfarin; Young Adult | 2016 |
17 other study(ies) available for dabigatran and Heart Diseases
| Article | Year |
|---|---|
Differences in the predictors of left atrial appendage thrombus between men and women treated with dabigatran or rivaroxaban.
Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Dabigatran; Female; Heart Diseases; Humans; Male; Retrospective Studies; Rivaroxaban; Thrombosis | 2022 |
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve-Induced Thrombin Generation.
Topics: Antithrombins; Dabigatran; Factor Xa Inhibitors; Heart Diseases; Heart Valve Prosthesis; Humans; Rivaroxaban; Thrombin; Thrombosis | 2020 |
Bleeding Complications After Use of Novel Oral Anticoagulants in Patients Undergoing Cardiac Surgery.
Topics: Aged; Anticoagulants; Blood Transfusion; Cardiac Surgical Procedures; Critical Care; Dabigatran; Female; Heart Diseases; Humans; Length of Stay; Male; Postoperative Hemorrhage; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Rivaroxaban | 2018 |
Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Contrast Media; Dabigatran; Dose-Response Relationship, Drug; Echocardiography, Transesophageal; Factor Xa Inhibitors; Female; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis | 2018 |
Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel.
Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Fatal Outcome; Heart Diseases; Heart Failure; Humans; Male; Thrombosis; Ticlopidine; Warfarin | 2018 |
Dabigatran as an alternative for atrial thrombosis resistant to rivaroxaban: A case report.
Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Drug Resistance; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Rivaroxaban; Thrombosis | 2018 |
Thrombolytic action of dabigatran in patients with acute pre-existing atrial thrombus.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Echocardiography, Transesophageal; Female; Heart Atria; Heart Diseases; Humans; Male; Thrombosis; Treatment Outcome | 2013 |
Dabigatran for left atrial thrombus.
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Atria; Heart Diseases; Humans; Thrombosis | 2013 |
Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran.
Topics: Aged; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Heart Diseases; Heart Ventricles; Humans; Incidental Findings; Male; Predictive Value of Tests; Thrombolytic Therapy; Thrombosis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2014 |
The antithrombotic effect of dabigatran.
Topics: Aged; Antithrombins; Atrial Appendage; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Echocardiography; Follow-Up Studies; Heart Diseases; Humans; Magnetic Resonance Imaging, Cine; Male; Multidetector Computed Tomography; Thrombosis | 2014 |
Myocardial infarction complicated by left ventricular thrombus and fatal thromboembolism following abrupt cessation of dabigatran.
Topics: Aged, 80 and over; Angiography; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Heart Diseases; Heart Ventricles; Humans; Male; Mesenteric Artery, Superior; Myocardial Infarction; Thromboembolism; Thrombosis; Tomography, X-Ray Computed | 2014 |
Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Family Practice; Female; Germany; Guideline Adherence; Heart Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Mass Screening; Middle Aged; Morpholines; Practice Guidelines as Topic; Process Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Thrombosis; Venous Thromboembolism | 2014 |
[Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy].
Topics: Antithrombins; Atrial Appendage; Atrial Fibrillation; Dabigatran; Echocardiography, Transesophageal; Factor Xa Inhibitors; Heart Diseases; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Rivaroxaban; Thrombosis; Treatment Outcome | 2016 |
Left atrial thrombus under dabigatran in a patient with nonvalvular atrial fibrillation.
Topics: Atrial Fibrillation; Dabigatran; Echocardiography; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Thrombosis; Treatment Failure | 2016 |
Development of Left Atrial Thrombus After Coadministration of Dabigatran Etexilate and Phenytoin.
Topics: Aged; Antithrombins; Cytochrome P-450 CYP1A2 Inducers; Dabigatran; Drug Interactions; Drug Therapy, Combination; Echocardiography, Transesophageal; Heart Atria; Heart Diseases; Humans; Male; Phenytoin; Pulmonary Embolism; Thrombosis | 2017 |
Mechanical valve thrombosis with dabigatran.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Diseases; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Middle Aged; Prosthesis Failure; Thrombosis | 2012 |
Direct thrombin inhibitors.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Blood Coagulation; Dabigatran; Heart Diseases; Heparin; Humans; Pipecolic Acids; Prodrugs; Pyridines; Sulfonamides; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |